Aethlon Medical, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AEMD Nasdaq 2834 www.aethlonmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aethlon Medical, Inc.

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - Dec 3rd, 2024 12:00 pm
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures - Nov 14th, 2024 2:09 pm
Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally - Nov 14th, 2024 1:00 pm
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Nov 14th, 2024 7:14 am
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Nov 13th, 2024 9:15 pm
Innovative Medical Technology Advances with First Patient Enrollments - Nov 12th, 2024 1:00 pm
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Nov 11th, 2024 4:18 pm
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia - Nov 11th, 2024 1:01 pm
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 - Nov 6th, 2024 1:01 pm
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now - Oct 29th, 2024 11:00 am
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR - Oct 25th, 2024 1:07 pm
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... - Oct 9th, 2024 10:26 pm
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 8th, 2024 12:01 pm
AEMD: Positive Takeaways from Life Science Investor Forum Presentation - Sep 24th, 2024 4:38 pm
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now - Sep 24th, 2024 11:00 am
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - Sep 20th, 2024 12:35 pm
Immunotherapy Clinical Trials - A New Approach to Treating Cancer - Sep 19th, 2024 2:00 pm
Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India - Sep 19th, 2024 12:01 pm
Aethlon Medical to Present at Virtual Investor Conferences in September - Sep 17th, 2024 12:01 pm
Innovation Driving Cancer's Solid Tumors Market - Sep 17th, 2024 11:30 am